Akari Therapeutics (AKTX) Change in Acquisitions & Divestments (2016)
Akari Therapeutics recorded quarterly Change in Acquisitions & Divestments of $35.1 million in Q4 2016, up 3342.67% quarter-over-quarter from $1.0 million in Q3 2016.
Akari Therapeutics' Change in Acquisitions & Divestments history runs 1 years deep, the most recent figure standing at $35.1 million for Q4 2016.
- In Q4 2016, Change in Acquisitions & Divestments changed N/A year-over-year to $35.1 million; the TTM figure through Dec 2017 stood at $36.1 million (changed N/A YoY), while the FY2017 annual figure was $10.0 million, down 72.24% from the prior year.
- Change in Acquisitions & Divestments came in at $35.1 million for Q4 2016 at Akari Therapeutics, up from $1.0 million in the prior quarter.
- In the past five years, Change in Acquisitions & Divestments ranged from a high of $35.1 million in Q4 2016 to a low of $1.0 million in Q3 2016.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Revolution Medicines | 32.39 Bn | 32.39 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2016 | 35.08 Mn |
| Dec 31, 2016 | 35.08 Mn |
| Sep 30, 2016 | 1.02 Mn |
| Sep 30, 2016 | 1.02 Mn |